Tag: MASTER DAPT
ESC 2022: MASTER DAPT continues to show merit for shortened dual antiplatelet therapy out to 15 months post-PCI
Fifteen-month results from the MASTER DAPT trial have shown that the preserved ischaemic benefit...
ESC 2021: One month DAPT is “becoming standard of care” for high bleeding risk patients following PCI
Marco Valgimigli (Lugano, Switzerland) talks to Cardiovascular News about the latest findin...
ESC 2021: One-month dual antiplatelet therapy post-stent implant benefits high bleeding risk patients
One month of dual antiplatelet therapy (DAPT) following stent implantation in high bleeding risk...
First patient enrolled in new study of abbreviated DAPT post-stent in high bleeding risk patients
Gillian Jessurun (Treant Zorggroep, Scheper Hospital Emmen, The Netherlands) has enrolled the first ...
